TERN Terns Pharmaceuticals, Inc.

HealthcareBiotechnology
$52.95
▲ 0.00%
43
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
33
Short-Term
53

Value

30
P/E-51.28
8
P/B4.90
45
P/S0.00
70
EV/EBITDA-38.55
5

Growth

37
Revenue Growth0.0%
28
EPS Growth8.0%
44
FCF Growth-17.3%
42

Momentum

84
12-Month Return1412.9%
100
3-Month Return37.5%
100
1-Month Return0.3%
54
RSI (14)75.00
79
50/200 MABullish
75

Profitability

20
ROE-20.0%
47
ROA-9.4%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-1.7%
1

Risk

36
Beta-0.38
20
60-Day Volatility28.6%
50

Generated 5/7/2026, 10:48:23 PM · How is this calculated?

QScore Analysis